Labeler
Breckenridge Pharmaceutical, Inc. NDC Codes
Breckenridge Pharmaceutical, Inc. lists 75 finished drug products in the FDA NDC Directory under NDC labeler code 51991.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Everolimus, Oxcarbazepine, Asenapine, Milnacipran Hydrochloride, Pomalidomide, Lacosamide, Duloxetine Delayed-Release, propranolol hydrochloride, Rivastigmine Transdermal System, Desvenlafaxine, Trimipramine, Tofacitinib, Zolpidem Tartrate, Tetracycline Hydrochloride, Eplerenone
- Active ingredients
- Everolimus, Oxcarbazepine, Asenapine maleate, Milnacipran hydrochloride, Pomalidomide, Lacosamide, Duloxetine hydrochloride, Propranolol hydrochloride, Rivastigmine, Desvenlafaxine succinate, Trimipramine maleate, Tofacitinib citrate
- NDC labeler codes
- 51991
- Strengths
- Everolimus 5 mg/1; Asenapine maleate 5 mg/1; Asenapine maleate 10 mg/1; Butalbital 50 mg/1; Caffeine 40 mg/1; Codeine phosphate 30 mg/1; Oxcarbazepine 150 mg/1; Oxcarbazepine 300 mg/1; Oxcarbazepine 600 mg/1; Tofacitinib citrate 5 mg/1; Tofacitinib citrate 10 mg/1; Zolpidem tartrate 6.25 mg/1; Zolpidem tartrate 12.5 mg/1; Milnacipran hydrochloride 12.5 mg/1; Milnacipran hydrochloride 50 mg/1; Milnacipran hydrochloride 100 mg/1; Milnacipran hydrochloride 25 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Pomalidomide 1 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Tablet, Extended release, Capsule, Delayed release pellets, Capsule, Extended release, Tablet, For suspension, Patch, Extended release, Injection, Solution, Injection, Solution, Concentrate, Injection
- Routes
- Oral, Sublingual, Intravenous, Transdermal, Intra-arterial, Intramuscular, Subcutaneous
- Drug classes (FDA established)
- Serotonin and Norepinephrine Reuptake Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Anti-epileptic Agent, Atypical Antipsychotic, Thalidomide Analog, beta-Adrenergic Blocker, Opioid Agonist, Aromatase Inhibitor, Cholinesterase Inhibitor, Tricyclic Antidepressant, Janus Kinase Inhibitor, gamma-Aminobutyric Acid A Receptor Positive Modulator, Tetracycline-class Antimicrobial, Aldosterone Antagonist, Anticholinergic, Estrogen, Progestin, Barbiturate, Central Nervous System Stimulant, Methylxanthine, Antirheumatic Agent, Catecholamine, Ergot Derivative, Allylamine Antifungal, Serotonin-3 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 149
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Tofacitinibtofacitinib citrate | Tofacitinib citrate 5 mg/1 | TabletOral | 51991-329 | 51991-0329-06 | — |
| Tofacitinibtofacitinib citrate | Tofacitinib citrate 10 mg/1 | TabletOral | 51991-963 | 51991-0963-06 | — |
| Zolpidem Tartrate | Zolpidem tartrate 6.25 mg/1 | Tablet, Extended releaseOral | 51991-981 | 51991-0981-01 | — |
| Zolpidem Tartrate | Zolpidem tartrate 12.5 mg/1 | Tablet, Extended releaseOral | 51991-982 | 51991-0982-01 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | TabletOral | 51991-034 | 51991-0034-06 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | TabletOral | 51991-036 | 51991-0036-06 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 100 mg/1 | TabletOral | 51991-037 | 51991-0037-06 | — |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 25 mg/1 | TabletOral | 51991-876 | 51991-0876-06 | — |
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | 51991-344 | 51991-0344-21 | — |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | 51991-346 | 51991-0346-21 | — |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | 51991-342 | 51991-0342-21 | — |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | 51991-343 | 51991-0343-21 | — |
| Everolimuseverolimus tablets | Everolimus 1 mg/1 | TabletOral | 51991-985 | 51991-0985-0651991-0985-99 | — |
| Dehydrated Alcoholalcohol | Alcohol 1 mL/mL | Injection, SolutionIntra-arterial | 51991-999 | 51991-0999-17 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | 51991-990 | 51991-0990-2851991-0990-77 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | 51991-991 | 51991-0991-2851991-0991-77 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | 51991-992 | 51991-0992-2851991-0992-77 | — |
| Methadone Hydrochloride | Methadone hydrochloride 10 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | 51991-002 | 51991-0002-98 | — |
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | 51991-348 | 51991-0348-0551991-0348-06 | — |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | 51991-349 | 51991-0349-0551991-0349-06 | — |
| Lacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | 51991-350 | 51991-0350-0551991-0350-06 | — |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | 51991-351 | 51991-0351-0551991-0351-06 | — |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | 51991-974 | 51991-0974-01 | — |
| Norepinephrine Bitartrate | Norepinephrine bitartrate 1 mg/mL | Injection, Solution, ConcentrateIntravenous | 51991-983 | 51991-0983-17 | — |
| Everolimuseverolimus tablets | Everolimus .25 mg/1 | TabletOral | 51991-379 | 51991-0379-0651991-0379-60 | — |
| Everolimuseverolimus tablets | Everolimus .5 mg/1 | TabletOral | 51991-380 | 51991-0380-0651991-0380-60 | — |
| Everolimuseverolimus tablets | Everolimus .75 mg/1 | TabletOral | 51991-381 | 51991-0381-0651991-0381-60 | — |
| Asenapineasenapine maleate | Asenapine maleate 5 mg/1 | TabletSublingual | 51991-359 | 51991-0359-1151991-0359-60 | — |
| Asenapineasenapine maleate | Asenapine maleate 5 mg/1 | TabletSublingual | 51991-358 | 51991-0358-1151991-0358-60 | — |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | 51991-821 | 51991-0821-2851991-0821-33 | — |
| Everolimus | Everolimus 5 mg/1 | TabletOral | 51991-822 | 51991-0822-2851991-0822-33 | — |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | 51991-823 | 51991-0823-2851991-0823-33 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | 51991-824 | 51991-0824-2851991-0824-33 | — |
| Asenapineasenapine maleate | Asenapine maleate 10 mg/1 | TabletSublingual | 51991-360 | 51991-0360-1151991-0360-60 | — |
| Asenapineasenapine maleate | Asenapine maleate 10 mg/1 | TabletSublingual | 51991-361 | 51991-0361-1151991-0361-60 | — |
| Asenapineasenapine maleate | Asenapine maleate 2.5 mg/1 | TabletSublingual | 51991-928 | 51991-0928-1151991-0928-60 | — |
| Exemestane | Exemestane 25 mg/1 | Tablet, Film coatedOral | 51991-005 | 51991-0005-90 | — |
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | 51991-897 | 51991-0897-30 | — |
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | 51991-898 | 51991-0898-30 | — |
| Rivastigmine Transdermal Systemrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | 51991-899 | 51991-0899-30 | — |
| Tetracycline Hydrochloride | Tetracycline hydrochloride 250 mg/1 | CapsuleOral | 51991-906 | 51991-0906-0151991-0906-0551991-0906-33 | — |
| Tetracycline Hydrochloride | Tetracycline hydrochloride 500 mg/1 | CapsuleOral | 51991-907 | 51991-0907-0151991-0907-0551991-0907-33 | — |
| Desvenlafaxinedesvenlafaxine succinate | Desvenlafaxine succinate 25 mg/1 | Tablet, Extended releaseOral | 51991-006 | 51991-0006-0151991-0006-1051991-0006-11+3 more | — |
| Eplerenone | Eplerenone 25 mg/1 | Tablet, Film coatedOral | 51991-877 | 51991-0877-1151991-0877-3351991-0877-90 | — |
| Eplerenone | Eplerenone 50 mg/1 | Tablet, Film coatedOral | 51991-878 | 51991-0878-1151991-0878-3351991-0878-90 | — |
| Duloxetine Delayed-Releaseduloxetine hydrochloride | Duloxetine hydrochloride 40 mg/1 | Capsule, Delayed release pelletsOral | 51991-750 | 51991-0750-0551991-0750-1051991-0750-33+1 more | — |
| Trimipramine | Trimipramine maleate 25 mg/1 | CapsuleOral | 51991-944 | 51991-0944-0151991-0944-33 | — |
| Trimipramine | Trimipramine maleate 50 mg/1 | CapsuleOral | 51991-945 | 51991-0945-0151991-0945-33 | — |
| Trimipramine | Trimipramine maleate 100 mg/1 | CapsuleOral | 51991-946 | 51991-0946-0151991-0946-33 | — |
| Desvenlafaxinedesvenlafaxine succinate | Desvenlafaxine succinate 50 mg/1 | Tablet, Extended releaseOral | 51991-311 | 51991-0311-0151991-0311-1051991-0311-11+4 more | — |
Breckenridge Pharmaceutical, Inc.: common questions
- What is Breckenridge Pharmaceutical, Inc.'s NDC labeler code?
- 51991. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Breckenridge Pharmaceutical, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.